Back to SYRE
B Group, Inc. SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$5.6M
Q3 2026
Peak value
$6.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $3.3M |
| Q1 2026 | $5M |
| Q2 2026 | $6.2M |
| Q3 2026 | $5.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $5.6M | 62.5K | — | — |
| Q2 2026 | $6.2M | 70.0K | — | — |
| Q1 2026 | $5M | 100.0K | — | — |
| Q4 2025 | $3.3M | 100.0K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M